1 Adam, D. Special report: The simulations driving the world's response to COVID-19. Nature, doi:10.1038/d41586-020-01003-6 (2020).
2 Prem, K. et al. The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study. The Lancet Public Health, doi:10.1016/S2468-2667(20)30073-6.
3 Harrison, C. Coronavirus puts drug repurposing on the fast track. Nat. Biotechnol., doi:10.1038/d41587-020-00003-1 (2020).
4 Zhang, B. et al. Treatment with convalescent plasma for critically ill patients with SARS-CoV-2 infection. Chest, doi:10.1016/j.chest.2020.03.039 (2020).
5 Shen, C. et al. Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma. JAMA, doi:10.1001/jama.2020.4783 (2020).
6 Zhou, F. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet 395, 1054-1062, doi:10.1016/S0140-6736(20)30566-3 (2020).
7 Mehta, P. et al. COVID-19: consider cytokine storm syndromes and immunosuppression. The Lancet 395, 1033-1034, doi:10.1016/S0140-6736(20)30628-0 (2020).
8 Huang, C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395, 497-506, doi:10.1016/s0140-6736(20)30183-5 (2020).
9 La Rosee, P. et al. Recommendations for the management of hemophagocytic lymphohistiocytosis in adults. Blood 133, 2465-2477, doi:10.1182/blood.2018894618 (2019).
10 Lee, D. W. et al. Current concepts in the diagnosis and management of cytokine release syndrome. Blood 124, 188-195, doi:10.1182/blood-2014-05-552729 (2014).
11 Shimabukuro-Vornhagen, A. et al. Cytokine release syndrome. Journal for immunotherapy of cancer 6, 56-56, doi:10.1186/s40425-018-0343-9 (2018).
12 Liu, Q., Zhou, Y.-h. & Yang, Z.-q. The cytokine storm of severe influenza and development of immunomodulatory therapy. Cell. Mol. Immunol. 13, 3-10, doi:10.1038/cmi.2015.74 (2016).
13 Huang, K.-J. et al. An interferon-γ-related cytokine storm in SARS patients. J. Med. Virol. 75, 185-194, doi:10.1002/jmv.20255 (2005).
14 Ai, T. et al. Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases. Radiology, 200642, doi:10.1148/radiol.2020200642 (2020).
15 Wang, Y. et al. Temporal Changes of CT Findings in 90 Patients with COVID-19 Pneumonia: A Longitudinal Study. Radiology, 200843, doi:10.1148/radiol.2020200843 (2020).
16 Alhazzani, W. et al. Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Med., doi:10.1007/s00134-020-06022-5 (2020).
17 Fardet, L. et al. Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome. Arthritis & rheumatology (Hoboken, N.J.) 66, 2613-2620, doi:10.1002/art.38690 (2014).
18 Machowicz, R., Janka, G. & Wiktor-Jedrzejczak, W. Your critical care patient may have HLH (hemophagocytic lymphohistiocytosis). Critical Care 20, 215, doi:10.1186/s13054-016-1369-3 (2016).
19 Allen, C., Yu, X., Kozinetz, C. & McClain, K. Highly elevated ferritin levels and the diagnosis of Hemophagocytic Lymphohistiocytosis. Pediatr. Blood Cancer 50, 1227-1235, doi:10.1002/pbc.21423 (2008).
20 Hayden, A. et al. Soluble interleukin-2 receptor is a sensitive diagnostic test in adult HLH. Blood Adv 1, 2529-2534, doi:10.1182/bloodadvances.2017012310 (2017).
21 Pedersen, S. F. & Ho, Y.-C. SARS-CoV-2: A Storm is Raging. The Journal of Clinical Investigation, doi:10.1172/JCI137647 (2020).
22 Chen, G. et al. Clinical and immunologic features in severe and moderate forms of Coronavirus Disease 2019. medRxiv, 2020.2002.2016.20023903, doi:10.1101/2020.02.16.20023903 (2020).
23 McGonagle, D., Sharif, K., O'Regan, A. & Bridgewood, C. The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease. Autoimmunity reviews, 102537, doi:https://doi.org/10.1016/j.autrev.2020.102537 (2020).
24 Tseng, Y.-T. et al. Causes, clinical symptoms, and outcomes of infectious diseases associated with hemophagocytic lymphohistiocytosis in Taiwanese adults. Journal of Microbiology, Immunology and Infection 44, 191-197, doi:https://doi.org/10.1016/j.jmii.2011.01.027 (2011).
25 Francois, B. et al. Thrombocytopenia in the sepsis syndrome: role of hemophagocytosis and macrophage colony-stimulating factor. Am. J. Med. 103, 114-120, doi:10.1016/s0002-9343(97)00136-8 (1997).
26 Schram, A. M. et al. Marked hyperferritinemia does not predict for HLH in the adult population. Blood 125, 1548-1552, doi:10.1182/blood-2014-10-602607 (2015).
27 Hui, P., Cook, D. J., Lim, W., Fraser, G. A. & Arnold, D. M. The frequency and clinical significance of thrombocytopenia complicating critical illness: a systematic review. Chest 139, 271-278, doi:10.1378/chest.10-2243 (2011).
28 Grom, A. A., Horne, A. & De Benedetti, F. Macrophage activation syndrome in the era of biologic therapy. Nat. Rev. Rheumatol. 12, 259-268, doi:10.1038/nrrheum.2015.179 (2016).
29 McCall, C. M. et al. Flow Cytometric Findings in Hemophagocytic Lymphohistiocytosis. Am. J. Clin. Pathol. 137, 786-794, doi:10.1309/ajcpp40mexwyrlpn (2012).
30 Lescure, F.-X. et al. Clinical and virological data of the first cases of COVID-19 in Europe: a case series. The Lancet Infectious Diseases, doi:10.1016/S1473-3099(20)30200-0.
31 Zheng, M. et al. Functional exhaustion of antiviral lymphocytes in COVID-19 patients. Cell. Mol. Immunol., doi:10.1038/s41423-020-0402-2 (2020).
32 Matthay, M. A. et al. Acute respiratory distress syndrome. Nature Reviews Disease Primers 5, 18, doi:10.1038/s41572-019-0069-0 (2019).
33 Delucchi, K. et al. Stability of ARDS subphenotypes over time in two randomised controlled trials. Thorax 73, 439-445, doi:10.1136/thoraxjnl-2017-211090 (2018).
34 Potey, P. M., Rossi, A. G., Lucas, C. D. & Dorward, D. A. Neutrophils in the initiation and resolution of acute pulmonary inflammation: understanding biological function and therapeutic potential. The Journal of pathology 247, 672-685, doi:10.1002/path.5221 (2019).
35 Liu, J. et al. Neutrophil-to-Lymphocyte Ratio Predicts Severe Illness Patients with 2019 Novel Coronavirus in the Early Stage. medRxiv, 2020.2002.2010.20021584, doi:10.1101/2020.02.10.20021584 (2020).
36 Zhang, C., Wu, Z., Li, J.-W., Zhao, H. & Wang, G.-Q. The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality. Int. J. Antimicrob. Agents, 105954-105954, doi:10.1016/j.ijantimicag.2020.105954 (2020).
37 Meduri, G. U. et al. Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time. Chest 107, 1062-1073, doi:10.1378/chest.107.4.1062 (1995).
38 Shakoory, B. et al. Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome: Reanalysis of a Prior Phase III Trial. Crit. Care Med. 44, 275-281, doi:10.1097/ccm.0000000000001402 (2016).
39 Néel, A. et al. Diagnostic and management of life-threatening Adult-Onset Still Disease: a French nationwide multicenter study and systematic literature review. Critical Care 22, 88, doi:10.1186/s13054-018-2012-2 (2018).
40 Dalbeth, N., Lauterio, T. J. & Wolfe, H. R. Mechanism of Action of Colchicine in the Treatment of Gout. Clin. Ther. 36, 1465-1479, doi:https://doi.org/10.1016/j.clinthera.2014.07.017 (2014).
41 Karakike, E. & Giamarellos-Bourboulis, E. J. Macrophage Activation-Like Syndrome: A Distinct Entity Leading to Early Death in Sepsis. Front. Immunol. 10, doi:10.3389/fimmu.2019.00055 (2019).
42 Gao, Z. C. [Efficient management of novel coronavirus pneumonia by efficient prevention and control in scientific manner]. Zhonghua Jie He He Hu Xi Za Zhi 43, E001, doi:10.3760/cma.j.issn.1001-0939.2020.0001 (2020).
43 World Health, O. Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected: interim guidance, 28 January 2020. (World Health Organization, Geneva, 2020).
44 Debaugnies, F. et al. Performances of the H-Score for Diagnosis of Hemophagocytic Lymphohistiocytosis in Adult and Pediatric Patients. Am. J. Clin. Pathol. 145, 862-870, doi:10.1093/ajcp/aqw076 (2016).
45 Chow, K. U., Luxembourg, B., Seifried, E. & Bonig, H. Spleen Size Is Significantly Influenced by Body Height and Sex: Establishment of Normal Values for Spleen Size at US with a Cohort of 1200 Healthy Individuals. Radiology 279, 306-313, doi:10.1148/radiol.2015150887 (2016).
46 Kennedy, P. A. & Madding, G. F. Surgical anatomy of the liver. Surg. Clin. North Am. 57, 233-244, doi:10.1016/s0039-6109(16)41180-1 (1977).
47 Verma, S. K. et al. Simple linear measurements of the normal liver: interobserver agreement and correlation with hepatic volume on MRI. Clin. Radiol. 65, 315-318, doi:10.1016/j.crad.2009.09.016 (2010).